Delivery Order SPE2DB22D2005-SPE2DB24FJTC2

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat respiratory conditions. The firm-fixed-price contract has a ceiling value of $2,654.88 and a period of performance through June 27, 2025. The contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The award has a ceiling value of $2,340.03 and an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used for the treatment of respiratory conditions. The award has a ceiling value of $12,191.57 and a completion date of June 11, 2025. This delivery order is not associated with a set-aside program, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $2,360.55 and a performance period through April 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription respiratory medication. The contract has a fixed-price delivery order type, with a ceiling value of $3,230.94, and is set to expire in August 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,852.01, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used to treat respiratory conditions. The contract is a firm fixed-price, non-set-aside award with a completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of fluticasone-salmeterol, a respiratory medication, with a ceiling value of $1,995.10. The award was made on August 19, 2024, with an ultimate completion date of August 20, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication. The award has a ceiling value of $5,662.53 and an ultimate completion date of September 9, 2024. The contract is a Firm Fixed Price arrangement, which is a common pricing type for federal pharmaceutical contracts. The award is not associated with any set-aside program....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medical product used in the treatment of respiratory conditions. The contract has a ceiling value of $2,748.73 and runs through March 13, 2025. The contract is a Firm Fixed Price, Delivery Order, with no set-aside designation. AmerisourceBergen...
This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,322.70, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product used in medical care. The contract has a Period of Performance through July 25, 2024 and is a Firm Fixed Price agreement. This award is part of a larger Indefinite...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJTC2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to support federal healthcare programs. The contract is a firm fixed-price delivery order with a ceiling value of $27,350.75 and a period of performance ending on September 24, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its extensive supply chain network, will provide these critical pharmaceutical products to military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to deliver a comprehensive range of medical commodities in support of government healthcare needs.

Generated 12/23/24, 2:46 PM